相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current concepts and approaches to merkel cell carcinoma
Marianna Babadzhanov et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2021)
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma
Shailender Bhatia et al.
CLINICAL CANCER RESEARCH (2020)
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
John W. Walker et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
Paul Nghiem et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Complementing the Cancer-Immunity Cycle
Ruben Pio et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma
Mahtab Samimi
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma
Shailender Bhatia et al.
CLINICAL CANCER RESEARCH (2019)
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies
Alessia Villani et al.
DERMATOLOGY AND THERAPY (2019)
Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus
Ioannis Gavvovidis et al.
CLINICAL CANCER RESEARCH (2018)
Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients
Linde M. van Veenendaal et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Are there multiple cells of origin of Merkel cell carcinoma?
J. C. Sunshine et al.
ONCOGENE (2018)
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma A Preplanned Interim Analysis of a Clinical Trial
Sandra P. D'Angelo et al.
JAMA ONCOLOGY (2018)
TIGIT: a novel immunotherapy target moving from bench to bedside
Benjamin L. Solomon et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy
Paul Nghiem et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Frequent detection of Merkel cell polyomavirus DNA in tissues from 10 consecutive autopsies
Giuseppe Mancuso et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Ipilimumab has efficacy in metastatic Merkel cell carcinoma: a case series of five patients
J. K. Winkler et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy
Gerald Goh et al.
ONCOTARGET (2016)
Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System
Kelly L. Harms et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma
M. Samimi et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma
Laurence Feldmeyer et al.
CLINICAL CANCER RESEARCH (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Merkel Cell Carcinoma: A Population Analysis on Survival
Vishwajith Sridharan et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Howard L. Kaufman et al.
LANCET ONCOLOGY (2016)
The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
Paul William Harms et al.
CANCER RESEARCH (2015)
Downregulation of MHC-I Expression Is Prevalent but Reversible in Merkel Cell Carcinoma
Kelly G. Paulson et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
Olga K. Afanasiev et al.
CLINICAL CANCER RESEARCH (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Tumor-Specific T Cells in Human Merkel Cell Carcinomas: A Possible Role for Tregs and T-Cell Exhaustion in Reducing T-Cell Responses
Mitra Dowlatshahi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Evan J. Lipson et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease
Kari Hemminki et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus
Scott J. Rodig et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer
Harri Sihto et al.
ONCOIMMUNOLOGY (2012)
Age-Specific Seroprevalence of Merkel Cell Polyomavirus, BK Virus, and JC Virus
Raphael P. Viscidi et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
Kelly G. Paulson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Asymptomatic Primary Merkel Cell Polyomavirus Infection among Adults
Yanis L. Tolstov et al.
EMERGING INFECTIOUS DISEASES (2011)
Skin cancers associated with autoimmune conditions among elderly adults
E. Lanoy et al.
BRITISH JOURNAL OF CANCER (2010)
Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays
Yanis L. Tolstov et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients:: the AEIOU features
Michelle Heath et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus
Masahiro Shuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Clonal integration of a polyomavirus in human Merkel cell carcinoma
Huichen Feng et al.
SCIENCE (2008)
Does chemotherapy improve survival in high-risk Stage I and II Merkel cell carcinoma of the skin?
MG Poulsen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Merkel cell carcinoma: Prognosis and treatment of patients from a single institution
PJ Allen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Merkel cell carcinoma and HIV infection
EA Engels et al.
LANCET (2002)
分享论文
